FIELD: medicine.
SUBSTANCE: method involves introduction to a mammal of therapeutically effective amount of a compound exhibiting properties of antagonist of A2B receptor of the following formula: , where R1 and R2 independently represent lower alkyl, R3 represents hydrogen, X represents pyrazolene, Y represents lower alkylene, and Z represents phenyl or pyridyl which can be substituted with trifluoromethyl. Besides the invention covers a pharmaceutical composition.
EFFECT: accelerated wound healing in a mammal.
7 cl, 6 dwg, 2 tbl, 22 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREVENTION AND TREATMENT OF RESPIRATORY WAYS REMODELLING AND PNEUMONIA WITH APPLICATION OF ANTAGONISTS OF ADENOSINE RECEPTORS A | 2005 |
|
RU2391103C2 |
METHOD OF PRODUCING ANTAGONISTS OF ADENOSINE RECEPTORS A AND INTERMEDIATE PRODUCTS | 2004 |
|
RU2374247C2 |
METHOD OF PREVENTION AND TREATMENT OF LIVER DISEASE WITH APPLICATION OF RECEPTOR A ANTAGONISTS | 2007 |
|
RU2457842C2 |
ANTAGONISTS OF ADENOSINE A RECEPTORS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR THEIR PREPARING | 2002 |
|
RU2318824C2 |
DERIVATIVES OF XANTHINE AS ANTAGONISTS OF ADENOSINE A RECEPTORS | 2003 |
|
RU2318825C2 |
PRODRUG OF ADENOSINE A RECEPTOR ANTAGONISTS | 2006 |
|
RU2415858C2 |
PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS | 2009 |
|
RU2539568C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS NADPH-OXIDASE INHIBITORS | 2009 |
|
RU2538041C2 |
PHOSPHORUS(N)AMIDATEACETAL AND PHOSPH(OH)ATACETAL COMPOUNDS | 2019 |
|
RU2796403C2 |
PYRAZOLOPYRIMIDONE OR PYRROLOTRIAZONE DERIVATIVES, METHOD OF PREPARING SAME AND PHARMACEUTICAL APPLICATIONS THEREOF | 2014 |
|
RU2674977C2 |
Authors
Dates
2010-03-27—Published
2005-08-30—Filed